Amneal Pharmaceuticals Inc (2DT.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 08:14AM CEST. Market open.
| Previous close | 5.60 |
| Open | 5.40 |
| Bid | 5.60 x 0 |
| Ask | 5.80 x 0 |
| Day's range | 5.40 - 5.60 |
| 52-week range | 1.58 - 7.35 |
| Volume | |
| Avg. volume | 5 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 24, 2024--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
- Business Wire
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
BRIDGEWATER, N.J., April 16, 2024--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
- Business Wire
Amneal to Report First Quarter 2024 Results on May 3, 2024
BRIDGEWATER, N.J., April 10, 2024--Amneal to Report First Quarter 2024 Results on May 3, 2024
© 2024 Yahoo. All rights reserved.